Assessing Seasonality of Travel Distance to Harm Reduction Service Providers Among Persons Who Inject Drugs

Overview

Journal Harm Reduct J

Publisher Biomed Central

Specialties Pharmacology
Psychiatry

Date 2015 Oct 14

PMID 26458881

Authors

Sean T Allen

Monica S Ruiz

Amira Roess

Jeff Jones

Affiliations

Soon will be listed here.

Abstract

Background: Prior research has examined access to syringe exchange program (SEP) services among persons who inject drugs (PWID), but no research has been conducted to evaluate variations in SEP access based on season. This is an important gap in the literature given that seasonal weather patterns and inclement weather may affect SEP service utilization. The purpose of this research is to examine differences in access to SEPs by season among PWID in the District of Columbia (DC).

Findings: A geometric point distance estimation technique was applied to records from a DC SEP that operated from 1996 to 2011. We calculated the walking distance (via sidewalks) from the centroid point of zip code of home residence to the exchange site where PWID presented for services. Analysis of variance (ANOVA) was used to examine differences in walking distance measures by season. Differences in mean walking distance measures were statistically significant between winter and spring with PWID traveling approximately 2.88 and 2.77 miles, respectively, to access the SEP during these seasons.

Conclusions: The results of this study suggest that seasonal differences in SEP accessibility may exist between winter and spring. PWID may benefit from harm reduction providers adapting their SEP operations to provide a greater diversity of exchange locations during seasons in which inclement weather may negatively influence engagement with SEPs. Increasing the number of exchange locations based on season may help resolve unmet needs among injectors.

References

Rockwell R, Des Jarlais D, Friedman S, Perlis T, Paone D . Geographic proximity, policy and utilization of syringe exchange programmes. AIDS Care. 1999; 11(4):437-42. DOI: 10.1080/09540129947811. View

Hutchinson S, Taylor A, Goldberg D, Gruer L . Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990-94: implications for control and prevention of blood-borne viruses. Addiction. 2000; 95(6):931-40. DOI: 10.1046/j.1360-0443.2000.9569319.x. View

Birkmeyer J, Siewers A, Marth N, Goodman D . Regionalization of high-risk surgery and implications for patient travel times. JAMA. 2003; 290(20):2703-8. DOI: 10.1001/jama.290.20.2703. View

Hurley S, Jolley D, Kaldor J . Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet. 1997; 349(9068):1797-800. DOI: 10.1016/S0140-6736(96)11380-5. View

Holtgrave D, Pinkerton S, Jones T, Lurie P, Vlahov D . Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18 Suppl 1:S133-8. DOI: 10.1097/00042560-199802001-00022. View

Wodak A, Cooney A . Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006; 41(6-7):777-813. DOI: 10.1080/10826080600669579. View

Wodak A, McLeod L . The role of harm reduction in controlling HIV among injecting drug users. AIDS. 2008; 22 Suppl 2:S81-92. PMC: 3329723. DOI: 10.1097/01.aids.0000327439.20914.33. View

Berke E, Shi X . Computing travel time when the exact address is unknown: a comparison of point and polygon ZIP code approximation methods. Int J Health Geogr. 2009; 8:23. PMC: 2683820. DOI: 10.1186/1476-072X-8-23. View

Gindi R, Rucker M, Serio-Chapman C, Sherman S . Utilization patterns and correlates of retention among clients of the needle exchange program in Baltimore, Maryland. Drug Alcohol Depend. 2009; 103(3):93-8. PMC: 2744092. DOI: 10.1016/j.drugalcdep.2008.12.018. View

10.

Williams C, Metzger D . Race and distance effects on regular syringe exchange program use and injection risks: a geobehavioral analysis. Am J Public Health. 2010; 100(6):1068-74. PMC: 2866590. DOI: 10.2105/AJPH.2008.158337. View

11.

Kerr T, Small W, Buchner C, Zhang R, Li K, Montaner J . Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health. 2010; 100(8):1449-53. PMC: 2901279. DOI: 10.2105/AJPH.2009.178467. View

12.

Allen S, Ruiz M, ORourke A . How far will they go? Assessing the travel distance of current and former drug users to access harm reduction services. Harm Reduct J. 2015; 12:3. PMC: 4353450. DOI: 10.1186/s12954-015-0043-4. View